Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies

News provided by

Jul 07, 2015, 11:16 ET

DUBLIN, June 30, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/rt3mhz/deciphering) has announced the addition of the "Deciphering Global Major Pharmaceutical Companies' New Outsourcing Demands and Strategies" report to their offering.

It has been publicly recognized that global major pharmaceutical companies have been involved in a series of challenges in the recent years. The latest patent cliff has resulted in significant overcapacities in small molecule product manufacturing; increasingly challenging process in innovative drug R&D results in low R&D productivity; ever rising operation cost encounters with increasing demands for better and cheaper medicines by both payers and governments. All these factors have forced major companies to take radical initiatives in all aspects of their operation, in particular R&D and manufacturing.

To address these challenges, major pharma companies all have accordingly taken a series of strategies and actions in the past several years, including restructuring their internal operation through realigning their business segments and reducing overcapacities, changing their R&D strategies and focuses, increasing investment in innovation, and continuing improving efficiency and enhancing productivity through outsourcing more proportions of their core business. It is thus appropriate to say that global major companies are making transformational changes. Of all changes, externalization has become their core strategy.

The report, Deciphering Global Major Pharmaceutical Companies' New Outsourcing Demands and Strategies, published by JZMed, Inc, a world renowned market research firm specialized in pharmaceutical outsourcing, provides unique insights into global major pharmaceutical companies' new outsourcing demands and strategies in both R&D and manufacturing and in both small molecules and biologics. The report also includes the in-depth analyses on the new outsourcing models currently practiced by major pharma companies. More importantly, the report is designed to reveal the future changes in global major pharma companies' outsourcing demands and strategies.

The report provides readers a complete picture of global major pharmaceutical companies' current new outsourcing demands and strategies and a clear insight of their future development directions. It is a must-read book to all life science-related organizations that eagerly seek the information about the latest state of global major pharmaceutical companies' outsourcing practice, as well as the future development directions of their outsourcing demands and strategies.

Key Topics Covered:

Chapter One - Global Major Pharma Companies Making Transformational Changes
1.1 Introduction
1.2 Major pharma companies making transformational changes to improve efficiency, enhance productivity and achieve cost-effectiveness
1.3 Major pharma companies' new R&D focuses
1.4 Major pharma companies' new R&D strategies
1.5 Major pharma companies' new R&D models

Chapter Two - Global Major Pharma Companies' New R&D Outsourcing Demands and Strategies
2.1 Introduction
2.2 Major pharma companies' new drug discovery outsourcing demands and strategies
2.3 Major pharma companies' new preclinical development outsourcing demands and strategies
2.4 Major companies' new clinical development outsourcing demands and strategies

Chapter Three - Global Major Pharma Companies' New Manufacturing Outsourcing Demands and Strategies
3.1 Introduction
3.2 Major pharma companies' new manufacturing strategies on small molecule drugs
3.3 Major pharma companies' new outsourcing demands and strategies on small molecule drug manufacturing
3.4 Major pharma companies' new supply chain strategy for small molecule drugs
3.5 Major pharma companies' new biomanufacturing strategies
3.6 Major pharma companies' new outsourcing demands and strategies on biologic product manufacturing

Chapter Four - Global Major Pharma Companies' New Outsourcing Demands and Strategies in Emerging Markets
4.1 Introduction
4.2 Major pharma companies increasingly focusing on Asian markets
4.3 Major pharma companies' new outsourcing demands and strategies in China
4.4 Major pharma companies' new outsourcing demands and strategies in India
4.5 Major pharma companies' new outsourcing strategies in other key emerging markets

For more information visit http://www.researchandmarkets.com/research/rt3mhz/deciphering